Retraction notice to “Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer” [International Journal of Biological Macromolecules 245 (2023) 125510] (International Journal of Biological Macromolecules (2023) 245, (S0141813023024042), (10.1016/j.ijbiomac.2023.125510))

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the corresponding authors and the Editor-in-Chief. Concerns were raised about multiple instances of image duplication in Figs. 2, 3, 4, and 6 of the main article and Fig. 3 of the corrigendum. The images appear to depict the same samples but are labeled as different samples, with different areas, background colors, and focuses used to represent results from various cell lines. The authors requested the retraction of the article and regret any inconvenience caused to readers. Consequently, the Editor in Chief has decided to retract the article.